Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.
Aridis Pharmaceuticals, Inc. unveiled a licensing agreement with AstraZeneca PLC on 19 July, conferring exclusive global rights to...






